Zeke Miller @ZekeJMiller
WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use. https://t.co/7UM6hCxK48 — PolitiTweet.org